Overview

A Study in Patients With Erectile Dysfunction

Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate if treatment in erectile dysfunction with a long-acting drug (Tadalafil) taken once a day or taken as needed results in a longer treatment adherence and better long term outcomes (over 24 weeks), compared with a short-acting drug (Sildenafil Citrate) taken as needed.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Citric Acid
Sildenafil Citrate
Tadalafil